List of insiders holdings for Epizyme Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| BARRIS PETER J 10% Owner | 2016-01-12 17:32:04 | 0 6,261,599 | 6,261,599 | Form 4 |
| SANDELL SCOTT D 10% Owner | 2016-01-12 17:34:56 | 0 6,261,502 | 6,261,502 | Form 4 |
| KERINS PATRICK J 10% Owner | 2016-01-12 17:33:25 | 651 6,260,851 | 6,261,502 | Form 4 |
| Viswanathan Ravi 10% Owner | 2016-01-12 17:35:26 | 0 6,260,851 | 6,260,851 | Form 4 |
| BARRETT M JAMES 10% Owner | 2016-01-12 17:31:28 | 0 6,260,851 | 6,260,851 | Form 4 |
| Weller Harry R 10% Owner | 2016-01-12 17:35:59 | 0 6,260,851 | 6,260,851 | Form 4 |
| BASKETT FOREST 10% Owner | 2016-01-12 17:32:37 | 0 6,260,851 | 6,260,851 | Form 4 |
| KOLLURI KRISHNA KITTU 10% Owner | 2016-01-12 17:33:52 | 0 6,260,851 | 6,260,851 | Form 4 |
| SEIDENBERG BETH C Director | 2019-07-02 16:16:52 | 8,481 4,115,555 | 4,124,036 | Form 4 |
| KPCB XIII Associates LLC KLEINER PERKINS CAUFIELD & BYERS XIII LLC 10% Owner | 2019-02-14 13:44:52 | 3,838,167 0 | 3,838,167 | Form 13G |
| Celgene European Investment Co LLC CELGENE CORP 10% Owner | 2020-02-10 17:27:36 | 3,674,640 0 | 3,674,640 | Form 13G |
| BAY CITY CAPITAL LLC Bay City Capital Fund V Co-Investment Fund L.P. Bay City Capital Fund V L.P. Bay City Capital Management V LLC 10% Owner | 2016-01-12 16:30:17 | 0 3,380,951 | 3,380,951 | Form 4 |
| EVNIN LUKE GADICKE ANSBERT 10% Owner | 2014-02-11 15:54:38 | 0 2,413,819 | 2,413,819 | Form 4 |
| MPM BioVentures IV QP LP Scopa James Paul MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM BioVentures IV Strategic Fund L.P. Foley Todd KAILIAN VAUGHN M 10% Owner | 2016-02-09 18:33:53 | 1,729,674 0 | 1,729,674 | Form 13G |
| MPM BioVentures IV QP LP Scopa James Paul Vander Vort John MPM Asset Management Investors BV4 LLC MPM BioVentures IV GmbH & Co. Beteiligungs KG MPM BioVentures IV GP LLC MPM BioVentures IV LLC MPM BioVentures IV Strategic Fund L.P. Foley Todd KAILIAN VAUGHN M 10% Owner | 2016-02-09 18:33:53 | 1,729,674 0 | 1,729,674 | Form 13G |
| DRANT RYAN D 10% Owner | 2014-08-18 17:46:43 | 455 1,725,906 | 1,726,361 | Form 4 |
| Gould Robert J Director | 2015-12-31 10:23:03 | 722,035 0 | 722,035 | Form 4 |
| Astellas Venture Fund I L.P. Astellas Venture Management LLC 10% Owner | 2013-06-06 20:27:19 | 650,253 0 | 650,253 | Form 4 |
| Zhang Yi 10% Owner | 2013-05-30 19:23:27 | 495,299 0 | 495,299 | Form 3 |
| Amgen Ventures LLC AMGEN INC 10% Owner | 2013-06-05 16:01:48 | 334,126 0 | 334,126 | Form 4 |
| Bazemore Robert B President & CEO | 2021-03-29 16:30:13 | 322,626 0 | 322,626 | Form 4 |
| Rhodes Jason P President, CFO and Treasurer | 2014-09-24 18:15:43 | 287,459 0 | 287,459 | Form 4 |
| Hedrick Eric Chief Medical Officer | 2014-10-17 18:52:11 | 276,929 0 | 276,929 | Form 4 |
| Horvitz H Robert 10% Owner | 2013-05-30 19:24:34 | 239,655 24,660 | 264,315 | Form 3 |
| Ros Matthew See Remarks | 2021-08-18 08:02:56 | 245,491 0 | 245,491 | Form 4 |
| Graf Susan E Chief Business Officer | 2018-02-13 17:05:56 | 106,344 0 | 106,344 | Form 4 |
| Singer Andrew E. EVP & CFO | 2017-08-10 15:47:35 | 89,712 0 | 89,712 | Form 4 |
| Copeland Robert A President of Research and CSO | 2017-06-07 13:48:55 | 67,588 0 | 67,588 | Form 4 |
| Allen Andrew R Director | 2021-06-15 16:37:03 | 61,119 0 | 61,119 | Form 4 |
| TOMBESI PAOLO Chief Financial Officer | 2021-02-05 16:40:56 | 53,465 0 | 53,465 | Form 4 |
| Vakiener Victoria Chief Commercial Officer | 2021-02-05 16:32:30 | 52,685 0 | 52,685 | Form 4 |
| Garbacz Stephen Principal Accounting Officer | 2014-11-04 18:35:35 | 34,775 0 | 34,775 | Form 4 |
| Fleming Suzanne SVP | 2018-02-13 17:02:54 | 29,002 0 | 29,002 | Form 4 |
| Shiosaki Kazumi Director | 2013-06-06 16:48:40 | 17,666 0 | 17,666 | Form 4 |
| Ho Peter Tai-Ching Chief Development Officer | 2017-10-25 12:29:58 | 13,623 2,000 | 15,623 | Form 4 |
| POPS RICHARD F Director | 2020-06-02 16:15:55 | 14,013 0 | 14,013 | Form 4 |
| Giordano Michael F Director | 2022-08-16 19:03:16 | 0 0 | 0 | Form 4 |
| GOLDFISCHER CARL Director | 2022-08-16 19:02:25 | 0 0 | 0 | Form 4 |
| Conroy Kevin T Director | 2022-08-16 19:02:02 | 0 0 | 0 | Form 4 |
| Richon Victoria Director | 2022-08-16 18:59:10 | 0 0 | 0 | Form 4 |
| MOTT DAVID M Director | 2022-08-16 18:59:01 | 0 0 | 0 | Form 4 |
| BEVERIDGE ROY A Director | 2022-08-16 18:58:50 | 0 0 | 0 | Form 4 |
| Agarwal Shefali See Remarks | 2022-08-16 18:57:54 | 0 0 | 0 | Form 4 |
| Legorreta Pablo G. RP Management LLC RPI Finance Trust Royalty Pharma Investments 2019 ICAV Director 10% Owner | 2022-08-16 18:55:40 | 0 0 | 0 | Form 4 |
| Beaulieu Joseph See Remarks | 2022-08-16 18:55:17 | 0 0 | 0 | Form 4 |
| Korn Jerald Chief Operating Officer | 2022-08-16 18:55:41 | 0 0 | 0 | Form 4 |
| BATE KENNETH Director | 2022-08-16 18:55:00 | 0 0 | 0 | Form 4 |
| Kutok Jeffery Chief Scientific Officer | 2022-08-16 18:54:59 | 0 0 | 0 | Form 4 |
| Stuckley Carol Director | 2022-08-16 18:54:41 | 0 0 | 0 | Form 4 |
| Bogle Grant C. President and CEO | 2022-08-16 18:52:01 | 0 0 | 0 | Form 4 |
| Daniel Thomas O Director | 2013-05-30 19:25:20 | 0 0 | 0 | Form 3 |
| NEW ENTERPRISE ASSOCIATES 13 LP NEA Partners 13 Limited Partnership NEA 13 GP Ltd 10% Owner | 2019-07-08 16:10:43 | 0 0 | 0 | Form 13D |